You are 3 steps away
from making better decisions

Serving leading biopharmaceutical companies globally:

AstraZeneca
Harvard Business School
Mallinckrodt
McKesson
Baxter
Dow

Last Updated: September 27, 2020

DrugPatentWatch Database Preview

Litigation Details for In Re Koninklijke Philips Patent Litigation (N.D. Cal. 2018)

➤ Get the DrugPatentWatch Daily Briefing
» See Plans and Pricing

« Back to Dashboard

In Re Koninklijke Philips Patent Litigation (N.D. Cal. 2018)

Docket   Start Trial Date Filed 2018-04-03
Court District Court, N.D. California Date Terminated
Cause 35:271 Patent Infringement Assigned To Haywood Stirling Gilliam Jr.
Jury Demand Plaintiff Referred To Alex G. Tse
Parties ACER AMERICA CORPORATION; ACER INC.; MICROSOFT CORPORATION; MICROSOFT MOBILE OY; YIFANG USA, INC.
Patents 10,022,447; 10,028,946; 10,028,962; 10,028,963; 10,034,879; 10,041,934; 10,064,406; 10,064,948; 10,071,962; 10,076,514; 10,077,447; 10,081,665; 10,085,974; 10,092,659; 10,092,706; 10,092,738; 10,093,654; 10,093,934; 10,098,860; 10,098,910; 10,098,970; 10,105,389; 10,105,436; 10,106,620; 10,106,808; 10,117,844; 10,117,886; 10,117,909; 10,119,976; 10,123,876; 10,143,665; 10,143,731; 10,143,752; 10,143,792; 10,143,905; 10,149,809; 10,149,876; 10,150,817; 10,150,827; 10,154,971; 10,154,990; 10,155,960; 10,161,928; 10,179,811; 10,179,888; 10,206,956; 10,212,957; 10,238,742; 10,251,778; 10,251,888; 10,251,934; 10,265,288; 10,265,595; 10,285,910; 10,286,330; 10,307,417; 10,314,846; 10,314,855; 10,314,886; 10,314,898; 10,314,910; 10,330,679; 10,369,113; 10,377,797; 10,377,809; 10,377,832; 10,387,930; 10,390,753; 10,393,751; 10,393,789; 10,398,955; 10,406,102; 10,406,128; 10,406,143; 10,413,564; 10,414,831; 10,420,838; 10,420,839; 10,441,587; 10,441,595; 10,441,630; 10,441,639; 10,488,413; 10,526,381; 10,526,389; 10,526,390; 10,526,488; 10,548,876; 10,564,140; 10,568,950; 10,596,101; 10,617,742; 10,624,846; 10,624,875; 10,626,151; 10,631,974; 10,632,123; 10,632,251; 6,028,071; 6,053,827; 6,056,970; 6,071,706; 6,080,913; 6,083,907; 6,090,785; 6,154,706; 6,183,969; 6,183,974; 6,251,587; 6,284,711; 6,316,259; 6,316,475; 6,344,215; 6,361,817; 6,406,387; 6,406,731; 6,413,176; 6,417,237; 6,436,706; 6,436,713; 6,488,962; 6,514,529; 6,536,975; 6,564,385; 6,565,870; 6,574,971; 6,575,854; 6,602,962; 6,602,989; 6,673,574; 6,673,838; 6,696,090; 6,706,724; 6,723,303; 6,726,918; 6,753,073; 6,773,960; 6,774,122; 6,821,975; 6,827,659; 6,827,955; 6,830,521; 6,830,766; 6,830,898; 6,844,390; 6,846,844; 6,858,580; 6,858,596; 6,872,156; 6,872,390; 6,872,397; 6,872,569; 6,875,137; 6,875,447; 6,887,832; 6,902,548; 6,902,550; 6,902,718; 6,905,429; 6,905,886; 6,913,932; 6,915,154; 6,923,738; 6,945,886; 6,949,035; 6,949,036; 6,949,251; 6,955,717; 6,955,875; 6,958,303; 6,960,564; 6,962,151; 6,969,330; 6,969,514; 6,989,138; 7,018,806; 7,018,992; 7,022,014; 7,052,713; 7,055,869; 7,056,886; 7,060,673; 7,070,827; 7,083,808; 7,097,631; 7,097,860; 7,105,489; 7,108,974; 7,125,564; 7,125,836; 7,125,875; 7,125,879; 7,125,905; 7,137,913; 7,149,631; 7,214,695; 7,217,510; 7,217,713; 7,217,858; 7,220,742; 7,247,316; 7,247,318; 7,255,983; 7,255,990; 7,311,620; 7,314,436; 7,314,624; 7,314,971; 7,318,325; 7,341,989; 7,358,393; 7,361,807; 7,361,808; 7,381,141; 7,393,674; 7,393,994; 7,417,176; 7,429,488; 7,429,602; 7,429,659; 7,488,316; 7,488,827; 7,491,854; 7,510,726; 7,514,075; 7,536,215; 7,550,595; 7,572,621; 7,575,914; 7,579,377; 7,595,140; 7,622,102; 7,626,077; 7,632,858; 7,659,112; 7,674,799; 7,674,811; 7,687,467; 7,696,168; 7,696,314; 7,696,406; 7,713,150; 7,713,573; 7,713,914; 7,713,999; 7,718,128; 7,718,702; 7,718,783; 7,722,857; 7,731,986; 7,731,989; 7,757,854; 7,765,107; 7,771,966; 7,774,978; 7,775,914; 7,786,158; 7,786,288; 7,795,316; 7,795,414; 7,803,778; 7,806,265; 7,807,436; 7,807,799; 7,811,572; 7,811,587; 7,838,053; 7,838,564; 7,858,122; 7,858,594; 7,858,643; 7,875,283; 7,875,630; 7,879,377; 7,879,976; 7,887,832; 7,888,489; 7,901,385; 7,901,905; 7,910,141; 7,914,782; 7,923,564; 7,923,598; 7,928,122; 7,928,132; 7,955,200; 7,955,809; 7,960,596; 7,963,946; 7,973,031; 7,975,690; 7,976,838; 7,976,870; 7,976,886; 7,979,773; 7,989,415; 7,989,477; 7,989,596; 8,007,806; 8,008,447; 8,029,391; 8,029,817; 8,033,934; 8,034,809; 8,034,839; 8,071,569; 8,071,643; 8,071,644; 8,071,795; 8,076,536; 8,083,620; 8,088,786; 8,088,789; 8,092,832; 8,097,769; 8,101,564; 8,105,626; 8,114,394; 8,114,616; 8,114,909; 8,114,969; 8,127,839; 8,128,960; 8,142,792; 8,153,616; 8,158,414; 8,168,616; 8,168,620; 8,168,624; 8,168,644; 8,187,630; 8,187,632; 8,187,855; 8,187,879; 8,247,397; 8,283,179; 8,283,369; 8,287,910; 8,303,986; 8,315,886; 8,318,441; 8,318,674; 8,318,706; 8,318,817; 8,323,630; 8,324,242; 8,324,283; 8,344,153; 8,361,488; 8,361,536; 8,361,955; 8,377,902; 8,389,215; 8,394,367; 8,394,387; 8,394,406; 8,394,766; 8,395,021; 8,414,846; 8,414,888; 8,415,395; 8,420,330; 8,420,674; 8,420,792; 8,436,149; 8,470,853; 8,475,414; 8,475,807; 8,475,831; 8,475,839; 8,491,893; 8,491,917; 8,523,127; 8,529,875; 8,529,898; 8,529,928; 8,529,945; 8,529,948; 8,536,161; 8,536,200; 8,550,654; 8,550,915; 8,569,015; 8,569,017; 8,569,325; 8,573,565; 8,574,259; 8,574,569; 8,574,622; 8,574,626; 8,574,855; 8,579,869; 8,580,765; 8,580,858; 8,595,105; 8,602,215; 8,616,385; 8,617,594; 8,617,595; 8,617,598; 8,617,840; 8,617,876; 8,624,077; 8,632,773; 8,672,898; 8,673,574; 8,674,176; 8,679,488; 8,679,521; 8,679,621; 8,679,751; 8,679,778; 8,679,806; 8,679,839; 8,679,844; 8,690,967; 8,702,654; 8,741,873; 8,742,183; 8,753,621; 8,753,679; 8,765,150; 8,771,769; 8,771,960; 8,778,324; 8,778,390; 8,778,393; 8,778,394; 8,778,441; 8,778,620; 8,778,622; 8,778,675; 8,778,962; 8,785,142; 8,785,369; 8,785,385; 8,785,415; 8,785,420; 8,785,616; 8,795,107; 8,795,108; 8,795,659; 8,795,673; 8,795,962; 8,808,786; 8,809,059; 8,809,271; 8,809,307; 8,809,330; 8,809,378; 8,809,394; 8,812,100; 8,821,811; 8,821,872; 8,827,846; 8,828,391; 8,828,946; 8,831,905; 8,835,361; 8,835,429; 8,835,622; 8,840,887; 8,840,915; 8,840,928; 8,846,064; 8,846,066; 8,846,077; 8,846,091; 8,846,100; 8,846,112; 8,846,315; 8,846,587; 8,846,962; 8,846,976; 8,853,436; 8,853,476; 8,858,973; 8,858,987; 8,870,827; 8,888,595; 8,889,831; 8,912,122; 8,912,170; 8,912,187; 8,945,063; 8,945,602; 8,945,620; 8,945,621; 8,946,395; 8,950,397; 8,951,776; 8,956,291; 8,961,997; 8,962,000; 8,962,012; 8,962,028; 8,962,034; 8,962,572; 8,962,574; 8,962,630; 8,962,807; 8,962,860; 8,969,064; 8,969,355; 8,969,369; 8,969,377; 8,969,414; 8,969,566; 8,975,242; 8,978,966; 8,979,970; 8,992,975; 8,999,710; 8,999,915; 8,999,969; 8,999,970; 8,999,978; 8,999,979; 9,011,905; 9,023,807; 9,060,934; 9,067,989; 9,073,945; 9,078,726; 9,078,827; 9,078,838; 9,079,912; 9,079,949; 9,084,778; 9,084,797; 9,084,853; 9,085,558; 9,085,565; 9,090,945; 9,095,706; 9,096,827; 9,096,876; 9,096,907; 9,102,377; 9,102,742; 9,107,429; 9,107,827; 9,107,886; 9,107,898; 9,107,912; 9,107,960; 9,108,949; 9,108,975; 9,119,781; 9,125,905; 9,125,909; 9,125,910; 9,132,281; 9,149,579; 9,155,718; 9,155,738; 9,161,907; 9,161,918; 9,161,966; 9,161,978; 9,173,854; 9,220,695; 9,220,785; 9,237,945; 9,241,910; 9,241,946; 9,241,948; 9,248,355; 9,259,414; 9,265,724; 9,265,827; 9,265,831; 9,265,893; 9,271,949; 9,271,975; 9,271,990; 9,284,543; 9,284,564; 9,297,018; 9,314,447; 9,315,489; 9,315,574; 9,315,811; 9,315,838; 9,358,303; 9,381,179; 9,387,187; 9,393,090; 9,393,237; 9,393,318; 9,394,283; 9,394,344; 9,414,599; 9,414,620; 9,415,016; 9,415,025; 9,415,284; 9,429,574; 9,434,785; 9,434,922; 9,447,071; 9,447,141; 9,447,176; 9,447,184; 9,447,393; 9,488,643; 9,488,654; 9,488,665; 9,526,844; 9,529,976; 9,550,827; 9,566,286; 9,566,317; 9,572,797; 9,573,962; 9,574,010; 9,579,318; 9,580,488; 9,598,711; 9,598,718; 9,598,726; 9,616,114; 9,617,341; 9,622,361; 9,622,413; 9,622,971; 9,622,975; 9,622,983; 9,624,307; 9,630,975; 9,630,976; 9,631,164; 9,644,008; 9,675,587; 9,675,616; 9,675,639; 9,675,672; 9,675,696; 9,694,071; 9,694,078; 9,694,149; 9,695,434; 9,706,724; 9,713,617; 9,724,303; 9,724,323; 9,724,330; 9,724,358; 9,724,381; 9,724,394; 9,724,414; 9,731,179; 9,738,643; 9,738,718; 9,751,654; 9,752,099; 9,752,103; 9,752,138; 9,752,179; 9,765,150; 9,770,510; 9,789,057; 9,789,064; 9,789,078; 9,789,108; 9,789,125; 9,789,154; 9,789,156; 9,789,184; 9,795,138; 9,795,389; 9,795,672; 9,797,901; 9,797,907; 9,807,283; 9,808,523; 9,808,587; 9,809,521; 9,809,643; 9,809,776; 9,809,846; 9,821,051; 9,821,067; 9,821,114; 9,827,241; 9,827,242; 9,827,317; 9,828,415; 9,835,616; 9,835,622; 9,839,626; 9,839,675; 9,839,679; 9,844,574; 9,855,215; 9,855,241; 9,855,303; 9,855,344; 9,855,355; 9,872,854; 9,872,895; 9,879,067; 9,879,077; 9,879,088; 9,884,008; 9,884,016; 9,895,415; 9,901,113; 9,901,587; 9,901,626; 9,901,630; 9,901,724; 9,902,918; 9,907,751; 9,907,783; 9,907,797; 9,910,046; 9,913,489; 9,913,836; 9,913,860; 9,913,899; 9,913,901; 9,913,902; 9,913,910; 9,914,757; 9,914,769; 9,914,785; 9,915,643; 9,918,654; 9,918,973; 9,949,971; 9,949,994; 9,950,112; 9,950,125; 9,950,237; 9,951,368; 9,962,323; 9,962,397; 9,962,429; 9,962,548; 9,969,724; 9,969,786; 9,969,811; 9,970,041; 9,970,059; 9,974,742; 9,974,770; 9,974,773; 9,974,781; 9,976,140; 9,993,467; 9,999,595; RE43,258; RE43,390; RE43,580; RE43,711; RE43,797; RE43,799; RE43,879; RE44,038; RE44,186; RE44,599; RE44,733; RE44,872
Attorneys Aaron P Maurer; Amy Marie Bailey; Andrew Colin Mayo; Andrew Russell; Andrew V. Trask; Antoine M McNamara; Brian P. Wikner; Bruce R Genderson; Chad S. Campbell; Christina J McCullough; Christina Jordan McCullough; Christopher Alan Suarez; Christopher Scott Geyer; Craig R. Kaufman; David M. Fry; David M. Krinsky; Derek S. Neilson; Eleanor Gail Tennyson; Erika H. Warren; Erika Mayo; Hsiang James H Lin; Irene Inkyu Yang; Jared W. Crop; John W Shaw; Kaiwen Tseng; Karen Elizabeth Keller; Kevin Hardy; Kyle Thomason; Lucian C. Chen; Matthew S. Warren; Matthew Warren; Michael J Newton; Michael J. Bettinger; Michael Junwhan Song; Nathan Roger Hoeschen; Patrick Fitch; Patrick J. Flinn; Patrick J. McKeever; Patrick John McKeever; Patrick M. Shields; Patrick Shields; Ramsey M. Al-Salam; Richard A. Cederoth; Rodger Dallery Smith , II; Ross R. Barton; Sanjiv Prakash Laud; Sarah E. Stahnke; Sarah Elizabeth Fowler; Steven J. Balick; Theresa H Nguyen; Tiffany Patrice Cunningham; Tiffany Patrice Cunningham ,; Wing K. Chiu; Xavier Mark Brandwajn
Firms Alston & Bird LLP; Alston and Bird LLP; Alston Bird, LLP Dallas; Antoine M McNamara; Kevin Hardy; Kyle Thomason; LTL Attorneys LLP; Lucian C. Chen ,; Morris, Nichols, Arsht & Tunnell; Perkins Coie LLP; Perkins Colie LLP; Shaw Keller LLP; Sidley Austin LLP; Steptoe & Johnson LLP; TechKnowledge Law Group LLP; Warren Lex LLP; Williams & Connolly LLP; Wing K. Chiu ,
Link to Docket External link to docket
Small Molecule Drugs cited in In Re Koninklijke Philips Patent Litigation
The small molecule drugs covered by the patents cited in this case are   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial , and   Start Trial .
Biologic Drugs cited in In Re Koninklijke Philips Patent Litigation

The biologic drugs covered by the patents cited in this case are   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial , and   Start Trial .

Details for In Re Koninklijke Philips Patent Litigation (N.D. Cal. 2018)

Date Filed Document No. Description Snippet Link To Document
2017-07-11 241 quot;the '809 patent"), 6,772,114 ("the '114 patent"), & RE43,564 ("the …and a key agreement protocol." '819 patent, col. 711. 19-21. Defendants therefore argue that the…communication device is authenticated." '819 patent, col. 711. 49-51. Defendants, citing Pressure…5,910,797, 6,522,695, 8,543,819, 9,436,809, 6,772,114, RE43,564. Signed by Judge Gregory M. Sleet on 7/11/2017…5,910,797, 6,522,695, 8.;543,819, 9.436,809, 6,772,114, RE43,564 1 After having considered the submissions External link to document
2018-06-19 415 Exhibit A quot;the '809 patent"), 6,772,114 ("the '114 patent"), & RE43,564 ("the …and a key agreement protocol." '819 patent, col. 711. 19-21. Defendants therefore argue that the…communication device is authenticated." '819 patent, col. 711. 49-51. Defendants, citing Pressure…5,910,797, 6,522,695, 8.;543,819, 9.436,809, 6,772,114, RE43,564 1 After having considered the submissions….S. Patent Nos. RE 44,913 ("the '913 patent"), 6,690,387 ("the '387 patent" External link to document
2018-09-24 486 Filed 09/24/18 Page 8 of 9 297-18; 1888-401- …Philips Patent Litigation 3 April 2018 4:18-cv-01885-HSG 830 Patent Plaintiff External link to document
2018-11-01 530 Exhibit 315-324 9436809) OR (809 patent) 28. (RE43564) OR (RE 43,564) OR (RE43,564) OR (564 patent) 29. ((Philips) OR (Koninklijke…064 patent) OR (7,529,806) OR (7529806) OR (806 patent) OR (5,910,797) OR (5910797) OR (797 patent… (064 patent) 23. (7,529,806) OR (7529806) OR (806 patent) 24. (5,910,797) OR (5910797) OR (797 patent… Internet Explorer and Edge Browser The ’797 Patent Accused Functionalities …functionalities. With respect to the source code for the ’797 patent that Microsoft has already produced, we are confused External link to document
2018-11-01 534 this document is attached as 21 Exhibit 7. 22 14. On March 28, 2017, the parties submitted…Philips Patent Litigation 3 April 2018 4:18-cv-01885-HSG 830 Patent Plaintiff…MOTION FOR LEAVE TO 22 In Re Koninklijke Philips Patent Litigation AMEND ITS INFRINGEMENT … functionality accused of 11 infringing the patents-in-suit, as well as a non-limiting list of touchscreen…specific lists. For example, with respect to the ’913 patent, the accused 13 products were defined as: 14 External link to document
2018-11-05 549 Attachment 1 of the ’114 Patent. 11) ASUS’s infringement of U.S. Patent No. RE43,564 (“the ’564 Patent”): …of the ’806 Patent. 5) ASUS’s infringement of U.S. Patent No. 5,910,797 (“the ’797 Patent”): …infringes and continues to directly infringe the ’797 Patent in violation of 35 U.S.C. § 271(a)…equivalents, each element of claims 1 and 6 of the ’797 Patent. … 8,543,819, 9,436,809, 6,772,114, RE43,564 (D.I. 241) (“Markman External link to document
2018-11-08 554 Exhibit H (the “’114 patent”); and RE43,564 (the “’564 patent”) (collectively, the “Asserted Patents”). …the “’064 patent”); 7,529,806 (the “’806 patent”); 5,910,797 (the “’797 patent”); 6,522,695 (the “’695…695 patent”); RE44,006 (the “’006 patent”); 8,543,819 (the “’819 patent”); 9,436,809 (the “’809 patent”)…or more of U.S. Patent Nos. RE44,913 (the “’913 patent”); 6,690,387 (the “’387 patent”); 7,184,064 (the…Koninklijke Philips Patent Litigation 3 April 2018 4:18-cv-01885-HSG Patent Plaintiff External link to document
>Date Filed >Document No. >Description >Snippet >Link To Document

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

McKinsey
Baxter
Colorcon
Express Scripts
Johnson and Johnson
AstraZeneca

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.